What is the price target for DHT-U stock?
13 analysts have analysed DHT-U.CA and the average price target is 17.47 USD. This implies a price increase of 45.31% is expected in the next year compared to the current price of 12.02.
TSX:DHT-U • CA23344H1091
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DRI HEALTHCARE TRUST (DHT-U.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-29 | Scotiabank Capital | Maintains | Outperform |
| 2022-11-29 | STA Research | Maintains | Speculative Buy |
| 2022-11-08 | Scotiabank Capital | Maintains | Outperform |
| 2022-10-21 | Scotiabank Capital | Maintains | Outperform |
| 2022-10-21 | STA Research | Maintains | Speculative Buy |
| 2022-10-04 | Scotiabank Capital | Maintains | Outperform |
| 2022-10-04 | STA Research | Maintains | Speculative Buy |
| 2022-09-13 | Scotiabank Capital | Maintains | Outperform |
| 2022-08-04 | Scotiabank Capital | Maintains | Outperform |
| 2022-07-20 | Scotiabank Capital | Maintains | Outperform |
| 2022-03-11 | Canaccord Capital | Downgrade | Buy |
| 2022-03-09 | Scotiabank Capital | Downgrade | Outperform |
| 2022-03-03 | RBC Royalbank | Downgrade | Outperform |
| 2022-03-02 | Scotiabank Capital | Maintains | Outperform |
| 2022-03-01 | Scotiabank Capital | Maintains | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 158.912M 82.09% | 184.712M 16.24% | 188.924M 2.28% | 197.26M 4.41% | 205.08M 3.96% | 223.27M 8.87% | 237.89M 6.55% | 250.21M 5.18% | 277.7M 10.99% | 244.82M -11.84% | 250.33M 2.25% | |
| EBITDA YoY % growth | 96.71M 34.82% | 145.986M 50.95% | 152.547M 4.49% | 162.65M 6.62% | 170.76M 4.99% | 184.03M 7.77% | 195.13M 6.03% | 211.36M 8.32% | 237.35M 12.30% | 216.04M -8.98% | 255.13M 18.09% | |
| EBIT YoY % growth | 9.726M -21.99% | 43.117M 343.32% | 50.581M 17.31% | 60.272M 19.16% | 71.321M 18.33% | 75.073M 5.26% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 6.12% | 23.34% | 26.77% | 30.55% | 34.78% | 33.62% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 2.37 26.06% | 2.17 -8.44% | 2.26 4.15% | 2.29 1.30% | 2.41 5.15% | 2.83 17.48% | 3.63 28.21% | 3.81 5.01% | 3.81 | 3.02 -20.69% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.58 34.67% | 0.61 20.14% | 0.60 8.35% | 0.62 -19.55% | 0.42 -26.74% | 0.55 -10.99% | 0.56 -6.78% | 0.78 25.54% |
| Revenue Q2Q % growth | 48.089M 9.22% | 48.507M 9.92% | 48.207M -1.10% | 53.496M -13.30% | 49.793M 3.54% | 50.5M 4.11% | 50.5M 4.76% | 61.509M 14.98% |
| EBITDA Q2Q % growth | 45.353M 60.79% | 36.988M -21.10% | 38.045M -56.74% | 41.662M -66.95% | 36.168M -20.25% | 39.841M 7.71% | 37.603M -1.16% | N/A |
| EBIT Q2Q % growth | 16.514M 377.15% | 19.331M 75.13% | 17.301M 44.39% | 5.979M -75.19% | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed DHT-U.CA and the average price target is 17.47 USD. This implies a price increase of 45.31% is expected in the next year compared to the current price of 12.02.
DRI HEALTHCARE TRUST (DHT-U.CA) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of DRI HEALTHCARE TRUST (DHT-U.CA) is 0.58 USD and the consensus revenue estimate is 48.09M USD.
The expected long term growth rate for DRI HEALTHCARE TRUST (DHT-U.CA) is 5.54%.